Amgen takes aim at Alexion’s patents for Soliris PMLiVE
Just a short while ago Amgen was rumoured to be planning a bid for Alexion. Now, it’s filed a patent infringement action against Alexion’s top-selling drug Soliris.
Amgen takes aim at Alexion’s patents for Soliris PMLiVE
Just a short while ago Amgen was rumoured to be planning a bid for Alexion. Now, it’s filed a patent infringement action against Alexion’s top-selling drug Soliris.